Neurochemical and behavioral processes in gerontogenesis in conditions of experimental hyperglycemia.

Authors

  • O. Rodynskyi
  • K. Basysta
  • L. Guz

DOI:

https://doi.org/10.26641/2307-0404.2018.2.133691

Keywords:

experimental diabetes, experimental hyperglycemia, alloxan, diabetic encephalopathy, glial fibrillary acidic protein

Abstract

Many researchers are increasingly interested in the relation between diabetes and diabetic encephalopathy. At the moment, there are various experiments where this issue is considered. But despite prolonged studying, it is impossible to investigate this problem to the end. Cognitive deficit in hyperglycemia is also connected with aging. In the aging processes as in hyperglycemia the same pathogenetic factors play a role in the aging of the brain. It is also necessary to deeply analyze the neurochemical processes occurring in the brain in diabetes mellitus. The high incidence of complications is caused by tissue metabolism impairment in hyperglycemia. The study of neurochemical bases of brain activity is one of the leading and promising directions in the modern neuropathology. Scientists of different countries are searching for neurospecific damage markers of the brain substance in hyperglycemia.

Author Biographies

O. Rodynskyi

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Physiology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

K. Basysta

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Physiology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

L. Guz

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Physiology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Babah VN. [Treatment strategy and features of the clinic of mental disorders and psychosocial problems in patients with diabetes mellitus]. Mizhnarodnyi endo­krinologichnyi zhurnal. 2005;1:92-98. Russian.

Bobyreva LE. [Effect of phenolic antioxidants on the development of alloxan diabetes in rats]. Eksperi­men­tal'naya i klinicheskaya farmakologiya. 1997;60(3):51-53. Russian.

Borysiuk MV, Dosenko VYe, Byts YuV. [Con­dition of the elastolic system of the pancreas in the modeling of diabetes mellitus]. Fiziologichnyi zhurnal. 2002;48(5):17-21. Ukrainian.

Pal'chikova NA, Kuznecova NV, Kuz'minova OI, Selyatitskaya VG. [Hormonal-biochemical features of alloxan and streptozotocin models of experimental dia­betes]. Byulleten' SO RAMN. 2013;33(6):18-24. Russian.

BornsteinNM, Korczyn A, Brainin M, Guekht A,SkoogI.[Diabetes and the brain: questions and prob­lems]. Effektivnaya farmakoterapiya. 2014;39:50-56. Russian.

Yemel'yanov VV, Meshhaninov VN, Sarapul'cev PA. [Metabolic factors of accelerated aging of the orga­nism in patients with type 2 diabetes mellitus and their correction]. Gospital'nyy vestnik. 2007;2:20-32. Russian.

Leberfarb EYu, Rykova VI, Kolosova NG, et al. [Changes in the composition of rat proteoglycans in rats with age]. Byulleten' eksperimental'noy biologii i me­diciny. 2008;146(12):691-3. Russian.

Korkina MV, Elfimova EV. [Diabetes and cog­nitive aging]. Zhurnal nevrologii i psihiatrii. 2004;3:80-84. Russian.

Yemel'yanov VV, Ponomareva OS, Plotnikova EP, Severina TI, Kochergina MV. [Metabolic disorders and the rate of aging of an organism in patients with type 1 diabetes mellitus]. International Scientific and Practical Conference "Age-associated and gender peculiarities of health and disease". 2016;125-33. Russian.

GuzVA.[Mechanisms of defeat of the central and peripheral nervous system in conditions of expe­rimental diabetes mellitus]. Medicni perspektivi. 2009;XIV(3):4-14. Ukrainian.

Zinovieva OH. [Mechanisms of the functioning of the central and peripheral nervous system in conditions of experimental diabetes mellitus]. Medicni perspektivi. 2012;XVII(4):7-14. Ukrainian.

Mikhalyova LM, Gorshunova NK, Andryeva NV. [Diabetic microangiopathy in the elderly and senile age: clinical and morphological diagnostics and treatment]. Moskva, Medicinskoe informacionnoe agentstvo. 2009;176. Russian.

Smirnov AV, Shmidt MV, Pan'shin NG, Kuzne­cova VA. [Morphological changes in the hippocampus in the experimental modeling of diabetic encephalopathy]. Volgogradskiy nauchno-medicinskiy zhurnal. 2016;2:37-39. Russian.

Lankin VZ, Lisina MO, Arzamasceva NE, Kono­valova GG, Nedosugova LV, Kaminnyj AI, Tihaze AK, Ageev FT, Kuharchuk VV, Belenkov YuN. [Oxidative stress in atherosclerosis and diabetes]. Byulleten eksperi­mental'noy biologii i mediciny. 2005;140(7):48-51. Russian.

Hrytsiuk MI, Boichuk TM, Petryshen OI. [Com­parative characteristic of experimental models of diabetes mellitus]. Svit medycyny ta biologii. 2014;2(44):199-202. Ukrainian.

Zinkovich II,KhripachenkoIA, Kedenko LA, Savustianenko AV. [The role of autonomic regulation in the development of alloxan-induced diabetes mellitus in rats]. Endokrinologiia. 2005;10(1):35-40. Russian.

Yesin RG, Hajrullin IH, Esin OR. [Modern ideas about the mechanisms of cognitive disorders in diabetes mellitus]. Medicinskiy al'manah. 2013;1(25):135-7. Russian.

Sosina VB, Zaharov VV, Jahno NN. [Nonde­mantic cognitive impairments in patients with type 2 diabetes mellitus]. Nevrol. zhurnal. 2010;4:25-30. Russian.

GuzVA.[Condition of conditioned reflex and tentative-research activity of rats of different ages under conditions of aloxane diabetes]. Medicni perspektivi. 2011;XVI(1):4-10. Ukrainian.

StrokovIA, Zaharov VV, Strokov KI. [Diabetic encephalopathy]. Nevrologiya, neyropsihiatriya, psiho­somatika. 2012;2S:30-40. Russian.

Celuyko SS, Krasavina NP, Korneeva LS, Lashin SA, Ostronkov VS. [Morphofunctional characteristics of the pancreas and lung in experimental hyperglycemia with dihydroquercetin]. Еdited by Celuyko SS. Bla­goveshhensk, IPK ODEON. 2017;150. Russian.

Chernysheva EN, Panova TN. [Biological age and rate of aging in patients with metabolic syndrome, depending on anthropometric indicators]. Kubanskiy nau­chnyy medicinskiy vestnik. 2011;6:178-81. Russian.

Chernaya VI. [Influence of ionizing radiation on the protein content of intermediate gley filaments and the state of brain proteolysis]. Visnyk Dnipropetrovskogo derzhavnogo agrarnogo universytetu. 2010;2:26-29. Russian.

Chugunov PA, Semenova IV. [Diabetes mellitus and cognitive impairment]. Saharn. diab. 2008;161-8. Russian.

Mozhejko LA.[Experimental models for the study of diabetes mellitus. Part 1. Alloxan diabetes]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta. 2013;3:26-28. Russian.

Yastrebov AP, Meshhaninov VN. [Aging, lipid peroxidation and bio-age]. Yekaterinburg, Ural'skiy sle­dopyt. 2005;220. Russian.

Antia BS, Okokon JE. [Hypoglyacaemic effect of aqueous leaf extract of Persea Americana (Mill,) on alloxan induced diabetic rats]. Indian J Pharmacol. 2005;37(5):325-26.

Levin OS, Babkina OV. [Cerebrum diabeticum: is there a diabetic encephalopathy?]. Effektivnaya farma­koterapiya. 2016;29:32-36.

Bloom R, Schnaider-Beeri M, Rayona-Springer R, Heymann A, Dabush H, Bar L, Slater S, Rassovsky Y, Bahar-Fuchs A. [Computerized cognitive training for ol­der diabetic adults at risk of dementia: Study protocol for a randomized controlled trial]. Alzheimers Dement (N Y). 2017;3(4):636-50.

Das J, Vasan V, Sil PC. [Taurine exerts hypogly­cemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis]. Toxicol. Appl Pharmacol. 2012;258:296-308.

Dinesh KJ, Raj KA. [Anomalies in alloxan-iduced diabetic model: it is better to standardize it first].Ind.J. of Pharmacology. 2011;1(43):91.

Elsner M, Gurgul-Convey E, Lenzen S. [Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin- producing cells]. Free Radic Biol Med. 2006;41:825-34.

Macedo CS. [Experimental model of induction of diabetes mellitus in rats]. Plastic surgery, laboratory of plastic surgery:Sao Paulo- Paulista School of Medicine. 2005;2-5.

Frontczak-Baniewicz M, Struzynska L, Andry­chowski J. [Ultrastructural and immunochemical studies of glial scar formation in diabetic rats]. Acta. neurochir. suppl. 2010;106:51-55.

Gabbay KH, Merola LO, Field RA. [Sorbitol path­way: presence in nerve and cord with substrate accumu­lation in diabetes]. N. Engl. J. Med. 1988;319(9):542-8.

Golalipour MJ, Kaboli S, Kafshgiri, Ghafari S. Folia Morphol. 2012;71(2):71-77.

Malik RA, Masson ЕА, Sharma АК. [Hypoxic neuropathy: relevance to human diabetic neuropathy]. Science. 1966;151(707):209-10.

Federiuk IF. [Induction of type 1 diabetes rnel­litus in’ laboratory rats by use of attoxan route of admi­nistration, pitfalls, and insulin treatment]. Comprehensive Medicine. 2004;54:252-7.

Jing L, He Q, Zhang J, Li PA. [Temporal Profile of Astrocytes and Changes of Oligodendrocyte-Based Myelin Following Middle Cerebral Artery Occlusion in Diabetic and Non- diabetic Rats]. Int. J. Biol. Sci. 2013;9(2):190-9. doi: http://dx.doi.org/10.7150/ijbs.5844

Kaminitz A, Stein J,YanivI.[The vicious cycle of apoptotic beta-cell death in type 1 diabetes]. Immunol. Cell. Biol. 2007;85:582-9.

King AJ. [The use of animal models in diabetes research]. Br.J. Pharmacol. 2012;166(3):877-94.

Latha Velayudhan, Michaela Poppe, Nicola Ar­cher. [Risk of developing dementia in people with diabe­tes and mild cognitive impairment]. BJP. 2010;196:36-40.

Lenzen S. [The mechanisms of alloxan- and strep­tozotocin-induced diabetes]. Diabetologia. 2008;51:216-26.

Li ZG, Zhang W, Sima AA. [The role of im­paired insulin / IGF action in primary diabetic encepha­lopathy]. Brain Res. 2005;1037(1-2):12-24.

Min TS, Park SH. [Therapy of Diabetes Mellitus Using Experimental Animal Models]. Asian-Aust. J. Anim. Sci. 2010;23(5):672-9.

Szkudelski T. [The mechanism of alloxan and streptozotocin action B ceils of the rat pancreas]. Phy­siology. Res. 2001;50:536-46.

Tesfaye S, Malik R, Ward JD. [Vascular factors in diabetic neuropathy]. Diabetologia.1994;37(9):847-54.

Xu Y, Zhou H, Zhu Q. [The Impact of Micro­biota-Gut-Brain Axis on Diabetic Cognition Impairment]. Front. Aging Neurosci; 2017

Vermeer SE, Den Heijer T, Koudstaal PJ. [In­cidence and risk factors of silent brain infarcts in the population- based Rotterdam Scan Study]. Stroke. 2003;34(2):392-6.

Yan L-J. [Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress]. J. Diab. Re­search. 2014:1-11.

Downloads

How to Cite

1.
Rodynskyi O, Basysta K, Guz L. Neurochemical and behavioral processes in gerontogenesis in conditions of experimental hyperglycemia. Med. perspekt. [Internet]. 2018Jun.25 [cited 2024Nov.15];23(2):4-13. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/133691

Issue

Vol. 23 No. 2 (2018)

Section

THEORETICAL MEDICINE

License

Copyright (c) 2018 Medicni perspektivi (Medical perspectives)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.

Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.